Page last updated: 2024-08-24

triazoles and Disseminated Fungal Infection

triazoles has been researched along with Disseminated Fungal Infection in 154 studies

Research

Studies (154)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	90 (58.44)	24.3611
2020's	64 (41.56)	2.80

Authors

Authors	Studies
Bernards, S; de Boer, MGJ; Hendriks, BJC; Jolink, H; Koopmans, JG; van de Peppel, RJ; van der Beek, MT; van Grootveld, R; van Paassen, J; von dem Borne, PA	1
Clark, NM; Croos-Dabrera, R; Fisher, CE; Garcia-Diaz, J; Greenberg, RN; Kontoyiannis, DP; Kovanda, L; Miceli, MH; Nguyen, MH; Ostrosky-Zeichner, L; Spec, A; Thompson, GR; Young, JH	1
Leong, R; O'Flynn, R; Straus, W; Waskin, H; Zhou, YP	1
DiNardo, CD; DiPippo, AJ; Jiang, Y; Kadia, T; Kontoyiannis, DP; Maiti, A; Montalban-Bravo, G; Rausch, CR; Ravandi, F	1
Belotti, T; Campoli, C; Cojutti, PG; Gatti, M; Masetti, R; Pea, F; Pession, A; Viale, P	1
Kludjian, G; Miller, M; Mohrien, K; Morita, K	1
Cao, J; Chen, D; Fang, Y; Hu, Y; Li, F; Li, S; Lu, Y; Pei, R; Wu, M; Ye, P	1
Dong, R; Fang, Y; Jin, W; Lin, N; Shan, Q; Shi, C; Wang, L; Xie, Y; Ye, J	1
Aram, JA; Bellmann, C; Hongmei, J; Inês, M; Macmillan, T; Penack, O; Ping, Y; Webb, N	1
Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y	2
Hakki, M; Lewis, JS; Thompson, GR; Wiederhold, NP	1
Cai, Y; Chen, A; He, J; Ju, C; Li, S; Lian, Q; Wei, L; Xie, H; Zhao, B; Zhou, S	1
Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M	1
Gong, P; Guo, C; Guo, MB; Hou, Z; Wang, X; Xu, H; Yan, ZZ	1
Aguado, JM; Bodro, M; Carratalà, J; Cordero, E; Fariñas, MDC; Fernández-Ruiz, M; Fortún, J; Goikoetxea, J; Gutiérrez Martín, I; Illaro, A; López-Viñau, T; Moreno, A; Muñoz, P; Ramos-Martínez, A; Rodriguez-Álvarez, R; Ruiz-Ruigómez, M; Sabé, N; Salto-Alejandre, S; Valerio, M; Vidal, E	1
Feng, S; Shen, Y; Zhang, T	1
Cornely, OA; Franz, J; Jakobs, F; Jeck, J; Kron, A; Kron, F; Wingen-Heimann, SM	1
Bart, A; Biemond, BJ; Boelens, J; Bruns, AHW; Buil, JB; Cornelissen, JJ; de Jonge, N; Demandt, AMP; Doorduijn, JK; Dunbar, A; Godschalk, P; Haas, PA; Huygens, S; Janssen, JJWM; Kampinga, GA; Klaassen, CHW; Klein, SK; Lagrou, K; Maertens, J; Mercier, T; Moors, I; Oudhuis, G; Postma, DF; Reynders, M; Rijnders, BJA; Schauwvlieghe, AFAD; Selleslag, D; Span, LFR; van der Beek, MT; van der Velden, WJFM; van Dijk, K; Verweij, PE; von dem Borne, P; Zandijk, W	1
Denis, B; Madelaine, I; Pieragostini, R; Sauvageon, H; Touratier, S; Xhaard, A	1
Menna, P; Minotti, G; Salvatorelli, E	1
Garner, LM; Gonzalez, D; McCann, S; McKinzie, CJ; Sinha, J; Wilson, WS	1
Aram, JA; Engelhardt, M; Hamed, K; Huang, JJ; Kovanda, LL; Yan, J	1
Asai, N; Hagihara, M; Hirai, J; Iwamoto, T; Kato, H; Mikamo, H; Mori, N; Umemura, T; Yamagishi, Y	1
Buhl, C; Classen, AY; Cornely, OA; Heinz, WJ; Hoenigl, M; Karthaus, M; Khodamoradi, Y; Klein, M; Koehler, P; Koldehoff, M; Krause, R; Lass-Flörl, C; Liss, B; Maschmeyer, G; Mellinghoff, SC; Penack, O; Ruhnke, M; Schalk, E; Schmidt-Hieber, M; Sprute, R; Stemler, J; Teschner, D; Zapke, SE	1
Guarana, M; Nucci, M	1
Chen, H; Guo, J; Hu, L; Li, Y; Lin, H; Lu, X; Wu, W; Xiao, C	1
Chu, J; Tu, S; Wang, N; Xie, Z; Yang, L; Zhang, K	1
Barać, A; Benítez-Peñuela, MÁ; Cheng, MP; Cornely, OA; Desoubeaux, G; Falces-Romero, I; García-Vidal, C; Heinz, WJ; Herbrecht, R; Hoenigl, M; Ingram, P; Iqbal, N; Klimko, N; Klyasova, G; Koehler, P; Krause, R; Mehta, SR; Mellinghoff, SC; Ostermann, H; Penack, O; Ráčil, Z; Rodríguez, JY; Salmanton-García, J; Schalk, E; Seidel, D; Sheppard, DC; Vehreschild, JJ; Vehreschild, MJGT; Willinger, B; Wisplinghoff, H	1
Baddley, JW; Davis, MR; Mchardy, I; Nguyen, MH; Odermatt, A; Thompson, GR; Wittenberg, R; Young, BY	1
Benesch, M; Egger, M; Flaschberger, S; Gorkiewicz, G; Karastaneva, A; Kohlmaier, B; Lackner, H; Marterer, R; Seidel, M; Sperl, D; Strenger, V; Trobisch, A; Urban, C	1
Gandhi, TN; Linder, KA; Miceli, MH	1
Cardozo, C; Chumbita, M; García-Vidal, C; Moreno-García, E; Puerta-Alcalde, P	1
Angilletta, R; Corcione, S; De Rosa, FG; Lupia, T; Scabini, S	1
Arbona-Haddad, E; Bold, TD; Chen, K; Cheng, MP; Cummins, KC; Hammond, SP; Koo, S; Kusztos, AE; Liakos, A; Marty, FM; Orejas, JL; Pandit, A; Solomon, IH	1
Cho, SY; Chung, DR; Huh, K; Jung, CW; Kang, CI; Kim, SH; Lee, SY; Oh, J; Peck, KR	1
Cornely, OA; Hamed, K; Heinz, WJ; Herbrecht, R; Maertens, J; Marty, FM; Rahav, G; Schwartz, S	1
Baron, R; Berthou, C; Couturier, MA; Guillerm, G; Ianotto, JC; Le Bars, H; Le Clech, L; Narbonne, V; Nevez, G; Payan, C; Quinio, D; Saliou, P; Uguen, M	1
Alffenaar, JW; Bandodkar, S; Kesson, A; Lai, T; Roberts, JA	1
Calore, E; Cesaro, S; Colombini, A; Comelli, A; De Gregori, S; Decembrino, N; Giardini, I; Goffredo, BM; Molinaro, M; Muggeo, P; Perruccio, K; Scudeller, L; Soncini, E; Zecca, M	1
Anderson, A; Camargo, JF; Komanduri, KV; Lekakis, L; Martinez, OV; Mendoza, MA; Morris, MI; Prado, CE; Simkins, J	1
Athans, V; Brizendine, KD; Cober, E; Copley, MS; Siebenaller, C; Waldron, M; Welch, SC	1
Erbaş, G; Kalkanci, A; Köktürk, N; Özkurt, ZN; Pepeler, MS; Tunçcan, ÖG; Yegin, ZA; Yildirim, Z; Yildiz, Ş	1
Barton, R; Hardman, N; Hobson, R; Sandoe, J; Thomson, S; Wellberry-Smith, M; Young, N	1
Barker, J; Bogler, Y; Giralt, S; Gyurkocza, B; Lee, YJ; Papanicolaou, GA; Perales, MA; Seo, S; Shaffer, B; Stern, A; Su, Y; Tamari, R	1
Chen, J; Dadwal, S; Karras, NA; Pawlowska, A; Rosenthal, J; Ross, JA; Sun, W; Tegtmeier, B; Yamada, C; Zaia, J	1
Candoni, A; Facchin, G; Fanin, R; Lazzarotto, D	1
Cheah, R; Dendle, C; Gregory, G; Mohan, B; Tey, A	1
Maertens, J; Spriet, I; Van Daele, R	1
Cornely, OA; Koehler, P; Maurer, C; Müller, C; Stemler, J	1
Bernardo, V; Fernandez, AJ; Liverman, R; Miles, A; Tippett, A; Yildirim, I	1
Usayaporn, S; Vanichanan, J; Weeraphon, B	1
Li, X; Wei, XC; Xiao, X; Zhao, MF	1
Chen, SC; Cornely, OA; Hoenigl, M; Jenks, JD; Thompson, GR	1
Ishida, K; Wirth, F	1
Bai, J; Huang, M; Li, R; Liu, A; Liu, J; Liu, Y; Zhang, T	1
Jacobs, SE; Rana, MM; Saunders-Hao, P; Vu, CA	1
Steinbach, WJ	1
Alexander, S; Chen, L; Dang, H; Dvorak, CC; Esbenshade, AJ; Fisher, BT; Nieder, ML; Skeens, M; Steinbach, WJ; Sung, L; Villaluna, D; Zaoutis, TE	1
Kram, B; Liu, B; Maziarz, E; Spivey, J; Wrenn, R	1
Allegaert, K; Annaert, P; Colita, A; Dreesen, E; Elkayal, O; Smits, A; Spriet, I; Uyttebroeck, A; Van Daele, R	1
Bellanger, AP; Berceanu, A; Bichard, D; Deconinck, E; Gbaguidi-Haore, H; Millon, L; Monnot, T; Montange, D; Scherer, E; Tatoyan, N	1
Garcia-Vidal, C; Lamoth, F; Lichtenstern, C; Neofytos, D; Perrella, A; Vehreschild, JJ	1
Chen, J; Gao, X; Lai, J; Wang, B; Wu, C; Wu, J; Wu, Z; Yu, B; Zeng, H	1
Durand, ML; Kitt, TM; Marty, FM; Song, Y	1
Choi, EJ; Choi, SH; Kim, SH; Kim, YS; Lee, JH; Lee, KH; Lee, SO; Park, HS; Yang, E	1
Arrieta, AC; Chen, TK; Chu, J; Danziger-Isakov, LA; Day, JC; Desai, A; Frangoul, HA; Hamed, K; Jones, ME; Kovanda, LL; Lademacher, C; McComsey, GA; Micklus, K; Muller, WJ; Neely, M; Phillips, DL; Rheingold, SR; Statler, VA; Steinbach, WJ; Sue, PK; Walsh, TJ; Yildirim, I; Yin, DE	1
Chen, H; Chen, X; Deng, Q; Gao, S; Hu, J; Hu, Y; Huang, X; Jin, J; Li, J; Lin, D; Liu, L; Liu, Q; Shao, Z; Shen, J; Sun, Z; Wang, C; Wang, J; Wang, S; Wei, X; Wu, D; Wu, X; Yang, J; Zhang, X	1
Liu, Q; Marks, DI; Slavin, M	1
Hope, WW; Stott, KE	1
Bassetti, M; Bouza, E	1
Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E	1
Hope, WW; Kolamunnage-Dona, R; Kovanda, LL; Lee, M; Maertens, J; Neely, M	1
McCarthy, MW; Walsh, TJ	1
Aitken, SL; Granwehr, B; Heo, ST; Kontoyiannis, DP; Tverdek, FP	1
Assaf, A; Chaftari, AM; Hachem, R; Jiang, Y; Numan, Y; Raad, II; Shah, P	1
Abraham, A; Abraham, OC; Abubacker, FN; George, B; Korula, A; Lakshmi, KM; Mathews, V; Michael, JS; Rupali, P; Srivastava, A; Varghese, GM; Viswabandya, A	1
Baker, KK; Chin, A; Fredricks, DN; Hoofnagle, AN; Jain, R; Pergam, SA	1
Fallon, MJ; Liebenstein, TK; Widmer, KM	1
Chen, SC; Colombo, AL; de Almeida Júnior, JN; Slavin, MA; Sorrell, TC	1
Aragón, B; Cámara, R; Gozalbo, I; Grau, S; Jurado, M; Sanz, J	1
Feng, S; Han, M; He, Y; Jiang, E; Liu, L; Wang, Z; Wei, J; Yang, D; Zhai, W; Zhang, G; Zhang, L; Zhang, R; Zhang, S	1
Andes, D; Bonate, PL; Desai, AV; Hope, WW; Kovanda, LL; Kowalski, DL; Mouton, JW; Mujais, S; Townsend, RW	1
Aoun, M; Cornely, OA; Geddes, M; Grigg, A; Haider, S; Hammond, SP; Heinz, WJ; Hepler, DA; Kartsonis, NA; Maertens, J; Meyer, RG; Mullane, KM; Ostermann, H; Raad, I; Robertson, MN; Schanz, U; Ullmann, AJ; Van Iersel, MLPS; Waskin, H; Zimmerli, S	1
Benitez, L; Berglund, C; Marini, BL; Miceli, M; Nagel, JL; Perissinotti, AJ; Tang, LA	1
Behr, J; Ceelen, F; Ihle, F; Kneidinger, N; Matthes, S; Neurohr, C; Schramm, R; Stelzer, D; Vogeser, M; Weber, A; Winter, H; Zimmermann, G; Zoller, M	1
Amat, P; Calabuig, M; Hernández-Boluda, JC; Navarro, D; Pérez-Martínez, A; Solano, C; Tormo, M	1
Chauvin, C; Chevallier, P; Dalichampt, M; Deslandes, G; Garnier, A; Gastinne, T; Guillaume, T; Le Bourgeois, A; Le Gouill, S; Moreau, P; Paré, M; Pere, M; Peterlin, P	1
Bassetti, M; Cornely, OA; Dörfel, D; Hagel, S; Lehners, N; Mellinghoff, SC; Plis, A; Schalk, E; Vena, A	1
Alakel, N; Behre, G; Buchheidt, D; Christopeit, M; Cornely, OA; Hasenkamp, J; Kiehl, M; Koldehoff, M; Krause, SW; Lehners, N; Löhnert, AY; Maschmeyer, G; Mayer, K; Mellinghoff, SC; Ostermann, H; Panse, J; Penack, O; Ruhnke, M; Teschner, D; Ullmann, AJ; von Lilienfeld-Toal, M; Wolf, HH	1
Cangemi, G; Castagnola, E; Dufour, C; Mesini, A; Palmisani, E	1
Barco, S; Cangemi, G; Castagnola, E; Faraci, M; Giardino, S; Lanino, E; Mesini, A; Ricci, E	1
Denis, J; Herbrecht, R; Ledoux, MP; Nivoix, Y	1
Chen, C; Cornely, OA; Croos-Dabrera, R; Engelhardt, M; Heep, M; Lademacher, C; Maher, R; Marty, FM; Mullane, KM; Ostrosky-Zeichner, L; Perfect, JR	1
Chen, L; Dong, Y; Hao, R; Li, Y; Liu, L; Meng, T; Wang, Y; Zhang, T	1
Cornely, OA; Croos-Dabrera, R; Giladi, M; Lademacher, C; Lu, Q; Maher, RM; Marty, FM; Mullane, KM; Oren, I; Ostrosky-Zeichner, L; Perfect, JR; Rahav, G; Schmitt-Hoffmann, AH	2
Babik, JM; Chin-Hong, P; Doernberg, SB; Fung, M; Graff, L; Langelier, C; Lo, M; Logan, AC; Schwartz, BS; Tan, M	1
Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L	1
McCarthy, MW; Moriyama, B; Petraitiene, R; Petraitis, V; Walsh, TJ	1
Caracciolo, B; Carnovale, S; Gómez, S; Lede, R; Mussini, MS; Rosanova, MT; Sarkis, C; Sberna, N; Voto, C	1
Bose, P; DiPippo, AJ; Kontoyiannis, DP; Rausch, CR	1
Awdishu, L; Feist, A; Florez, R; Hays, S; Kozuch, JM; Singer, JP; Yung, G	1
Kontoyiannis, DP; Lewis, RE; Lionakis, MS	1
Ho, CL; Lee, CH; Lin, C; Lin, JC	1
Cesaro, S; Vicenzi, EB	1
Abbo, LM; Anjan, S; Beitinjaneh, A; Camargo, JF; Gibas, CFC; Lekakis, LJ; Martinez, OV; Rodriguez, A; Sanders, CJ; Wiederhold, NP	1
Blank, A; Carls, A; Egerer, G; Geist, MJP; Heinz, WJ; Hohmann, N; Mikus, G	1
Bienvenida, AF; Bubalo, JS; Forrest, GN; Furuno, JP; Holmes, CA; Lewis, JS; McGregor, JC; Noble, BN; Tallman, GB; Weber, BR	1
Aoun, M; Cornely, OA; Engelhardt, M; Giladi, M; Heinz, WJ; Herbrecht, R; Kaufhold, A; Kovanda, L; Maertens, J; Rahav, G; Saulay, M; Selleslag, D; Ullmann, AJ	1
Cheng, MP; Cummins, KC; Davids, MS; Issa, NC; Kubiak, DW; Marty, FM	1
Andersen, LO; Arendrup, MC; Hare, RK; Irga-Jaworska, N; Jaworski, R; Jensen, HE; Malecka, A; Nielsen, HV; Pomorska, A; Radon-Proskura, J	1
Brüggemann, RJ; Cordonnier, C; Cornely, OA; Duarte, RF; Girmenia, C; Kibbler, CC; Ljungman, P; Maertens, JA; Peter Donnelly, J; Racil, Z; Ribaud, P; Slavin, MA	1
Ahuja, T; Cirrone, F; Papadopoulos, J; Phillips, K; Siegfried, J	1
Andes, DR; Ghannoum, MA; Hope, WW; Jones, ME; Kovanda, LL; Lademacher, C; Lu, Q; Mukherjee, PK; Santerre Henriksen, A	1
Andes, D; Engelhardt, M; Groll, AH; Kaindl, T; Larger, P; Saulay, M	1
Deeren, D; Vulsteke, JB	1
Capellier, G; Clairet, AL; Lagoutte-Renosi, J; Millon, L; Navellou, JC; Piton, G; Rougny, AC; Winiszewski, H	1
Lestrade, PPA; Meis, JF; Melchers, WJG; Verweij, PE	1
Adamsick, ML; Elshaboury, RH; Gandhi, RG; Gift, T; Kotton, CN; Mansour, MK	1
Bagshaw, E; Floros, L; Kuessner, D; Posthumus, J; Sjölin, J	1
Boullié, A; Bretagne, S; Desnos-Ollivier, M; Dromer, F; Gautier, C; Lortholary, O	1
Hoenigl, M; Jenks, JD; Mehta, SR	1
Aversa, F; Busca, A; Candoni, A; Cesaro, S; Girmenia, C; Luppi, M; Nosari, AM; Pagano, L; Rossi, G; Venditti, A	1
Daly, RC; Kennedy, CC; Pennington, KM; Peters, S; Razonable, RR; Scott, JP; Wylam, M	1
Evans, SL; Fish, DN; Kiser, TH; MacLaren, R; Mueller, SW; Van Matre, ET	1
Arrieta, AC; Bradley, JS; Carmelitano, P; Gates, D; Groll, AH; Joshi, A; Kartsonis, NA; Lehrnbecher, T; Mangin, E; Paschke, A; Sung, L; Walsh, TJ; Waskin, H; Zwaan, CM	1
Claßen, AY; Egerer, G; Heimann, SM; Heinz, WJ; Kessel, J; Penack, O; Rachow, T; Vehreschild, JJ	1
Dolgov, E; Lee, A; Lee, MH; Perlin, DS; Prideaux, B; Zhao, Y; Zimmerman, M	1
Bowen, CD; Hakki, M; Lewis Ⅱ, JS; Tallman, GB	1
Angelucci, E; Aquino, S; Di Grazia, C; Dominietto, A; Furfaro, E; Ghiggi, C; Ghiso, A; Mikulska, M; Raiola, AM; Signori, A; Ungaro, R; Viscoli, C	1
Alffenaar, JC; Bakker, M; Märtson, AG; Span, LFR; Touw, DJ; van den Heuvel, ER; van der Werf, TS; Veringa, A	1
Floros, L; Georgallis, M; Pagliuca, A; Rita Capparella, M; Sung, AH; Taie, AA; Weidlich, D	1
Andes, DR; Bayless, M; Lepak, AJ; McCreary, EK; Schulz, LT; Van, AP; Wiebe, DA	1
Corcoran, TE; Ensor, CR; Hussain, S; Iasella, CJ; McDyer, JF; Moore, CA; Morrell, MR; Nero, JA; Nguyen, MH; Thanukrishnan, H; Venkataramanan, R	1
Chang, SC; Ko, BS; Lee, SH; Sun, HY	1
Bubalo, JS; Lewis, JS; Pham, AN	1
Clancy, CJ; Ensor, C; Joshi, R; Nguyen, MH; Shields, RK; Venkataramanan, R; Zhang, H; Zhao, W	1
Arnan, M; Duarte, RF; Pomares, H; Sánchez-Ortega, I; Sureda, A	1
Hope, WW; Kovanda, LL; Maher, R	1
Biehl, LM; Bücker, V; Cornely, OA; Franke, B; Liss, B; Markiefka, B; Persigehl, T; Scheid, C; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H	1
Benefield, RJ; Ditolla, K; Kim, JH	1
Barrueta, JA; Bow, EJ; Charbonneau, C; Cordonnier, C; Cornely, OA; Cragin, L; De Salas-Cansado, M; Garcia-Vidal, C; Jarque, I; Marks, DI; Pagliuca, A; Peral, C; Shaul, AJ; Slavin, M; Solano, C; Sorensen, S; Vanness, DJ	1
Bossaer, JB; Carico, R; Cluck, D; Harirforoosh, S; Murrell, D	1
Audisio, E; Aversa, F; Bruno, B; Busca, A; Candoni, A; Delia, M; Monaco, F; Mordini, N; Pagano, L; Passera, R; Vacca, A	1
Cheng, M; Haidar, G; Holland, SM; Sheridan, KR; Zelazny, AM; Zerbe, CS	1
Chang, YL; Chen, YL; Heitman, J; Wellington, M; Yu, SJ	1
Burgess, MJ; Crescencio, JC; Kothari, A; Shalin, SC	1
Cober, E; Neuner, E; Pallotta, A; Siebenaller, C; Weber, C; Welch, S	1
Groll, AH; Kyriakidis, I; Munchen, S; Tragiannidis, A	1
Girmenia, C; Iori, AP	1
Kim, L; Kuti, JL; Nicolau, DP; So, W; Thabit, AK	1
Bagshaw, E; Blackney, M; Cornely, OA; Escrig, C; Heimann, SM; Kuessner, D; Posthumus, J	1
Desai, AV; Engelhardt, M; Hope, WW; Kovanda, LL; Lademacher, C; Lu, Q; Maertens, J; Marty, FM	1

Reviews

38 review(s) available for triazoles and Disseminated Fungal Infection

Article	Year
Effectiveness and safety of isavuconazole prophylaxis for invasive fungal infections in the haematologic setting. Hematology (Amsterdam, Netherlands), 2022, Volume: 27, Issue:1 Topics: Adult; Antifungal Agents; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Triazoles	2022
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease. Future microbiology, 2022, Volume: 17 Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole	2022
New Perspectives on Antimicrobial Agents: Isavuconazole. Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9 Topics: Antifungal Agents; Candidiasis, Invasive; Caspofungin; Fungi; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Triazoles; Voriconazole	2022
Clinical research advances of isavuconazole in the treatment of invasive fungal diseases. Frontiers in cellular and infection microbiology, 2022, Volume: 12 Topics: Antifungal Agents; Aspergillosis; Candidiasis, Invasive; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Triazoles	2022
New Targeted Drugs for Acute Myeloid Leukemia and Antifungals: Pharmacokinetic Challenges and Opportunities. Chemotherapy, 2023, Volume: 68, Issue:3 Topics: Antifungal Agents; Cytochrome P-450 CYP3A; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Triazoles	2023
A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections. Mycoses, 2023, Volume: 66, Issue:9 Topics: Antifungal Agents; Humans; Invasive Fungal Infections; Triazoles; Voriconazole	2023
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). The Journal of antimicrobial chemotherapy, 2023, 08-02, Volume: 78, Issue:8 Topics: Antifungal Agents; Communicable Diseases; Cytochrome P-450 CYP3A; Hematologic Neoplasms; Hematology; Humans; Invasive Fungal Infections; Medical Oncology; Triazoles	2023
Should patients with acute myeloid leukemia treated with venetoclax-based regimens receive antifungal prophylaxis? Leukemia research, 2023, Volume: 131 Topics: Antifungal Agents; Azoles; Bridged Bicyclo Compounds, Heterocyclic; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles	2023
Prophylaxis of mould infections. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32 Suppl 2 Topics: Antifungal Agents; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Fungal Infections; Mycoses; Triazoles	2019
A Case Series and Literature Review of Isavuconazole Use in Pediatric Patients with Hemato-oncologic Diseases and Hematopoietic Stem Cell Transplantation. Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Aspergillus; Child; Child, Preschool; Drug Administration Schedule; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Mucor; Nitriles; Penicillium; Pyridines; Retrospective Studies; Transplantation, Homologous; Triazoles	2020
Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation. Expert opinion on drug metabolism & toxicology, 2020, Volume: 16, Issue:7 Topics: Antifungal Agents; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Humans; Invasive Fungal Infections; Salvage Therapy; Triazoles	2020
Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemma. Annals of hematology, 2020, Volume: 99, Issue:7 Topics: Antifungal Agents; Chemoprevention; Drug Interactions; Drugs, Investigational; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Prognosis; Staurosporine; Triazoles	2020
Breakthrough invasive fungal infections: Who is at risk? Mycoses, 2020, Volume: 63, Issue:10 Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillus; Candida; Central Venous Catheters; Echinocandins; Fluconazole; Fusarium; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Mucorales; Mycoses; Neutropenia; Opportunistic Infections; Organ Transplantation; Penicillium; Risk Factors; Triazoles	2020
Antifungal drugs: An updated review of central nervous system pharmacokinetics. Mycoses, 2020, Volume: 63, Issue:10 Topics: Antifungal Agents; Central Nervous System Fungal Infections; Echinocandins; Humans; Invasive Fungal Infections; Meningitis, Fungal; Polyenes; Pyrimidines; Triazoles	2020
Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies. BMC cancer, 2021, Apr-14, Volume: 21, Issue:1 Topics: Antifungal Agents; Echinocandins; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Network Meta-Analysis; Polyenes; Pre-Exposure Prophylaxis; Publication Bias; Treatment Outcome; Triazoles	2021
Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation. Expert review of anti-infective therapy, 2017, Volume: 15, Issue:5 Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Practice Guidelines as Topic; Primary Prevention; Transplantation, Homologous; Triazoles; Voriconazole	2017
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1 Topics: Antifungal Agents; Biological Availability; Drug Monitoring; Fungi; Humans; Invasive Fungal Infections; Itraconazole; Nitriles; Pyridines; Triazoles; Voriconazole	2017
Invasive mould infections in the ICU setting: complexities and solutions. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1 Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole	2017
Drug development challenges and strategies to address emerging and resistant fungal pathogens. Expert review of anti-infective therapy, 2017, Volume: 15, Issue:6 Topics: Antifungal Agents; Biomarkers; Candida; Candidiasis; Clinical Trials as Topic; Drug Design; Drug Resistance, Fungal; Echinocandins; Glycosides; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Triterpenes	2017
Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer. The Lancet. Infectious diseases, 2017, Volume: 17, Issue:11 Topics: Antifungal Agents; Biomarkers; Candida; Critical Illness; Decision Support Techniques; Diagnostic Tests, Routine; Echinocandins; Fungi; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Positron-Emission Tomography; Risk Assessment; Triazoles	2017
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Annals of hematology, 2018, Volume: 97, Issue:2 Topics: Antifungal Agents; Clinical Trials as Topic; Drug Monitoring; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Medical Oncology; Myelodysplastic Syndromes; Primary Prevention; Societies, Medical; Triazoles; Voriconazole	2018
Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity. Journal de mycologie medicale, 2018, Volume: 28, Issue:1 Topics: Animals; Antifungal Agents; Aspergillosis; Azoles; Candidemia; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Esterases; Humans; Invasive Fungal Infections; Mice; Mucormycosis; Nitriles; Pyridines; Triazoles	2018
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial. Mycoses, 2018, Volume: 61, Issue:7 Topics: Adult; Antifungal Agents; Fungi; Humans; Immunocompromised Host; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Middle Aged; Mucormycosis; Mycoses; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Rare Diseases; Renal Insufficiency; Triazoles	2018
Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis. BMC infectious diseases, 2018, 04-02, Volume: 18, Issue:1 Topics: Antifungal Agents; Blood Chemical Analysis; Chemoprevention; Drug Monitoring; Humans; Invasive Fungal Infections; Mycoses; Predictive Value of Tests; Reproducibility of Results; Treatment Outcome; Triazoles	2018
Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole. Clinical pharmacokinetics, 2018, Volume: 57, Issue:12 Topics: Adult; Animals; Antifungal Agents; Aspergillosis; Drug Interactions; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles	2018
Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:8 Topics: Antifungal Agents; Aspergillosis; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Invasive Fungal Infections; Network Meta-Analysis; Neutropenia; Opportunistic Infections; Randomized Controlled Trials as Topic; Triazoles	2018
Posaconazole in immunocompromised pediatric patients. Expert review of anti-infective therapy, 2018, Volume: 16, Issue:7 Topics: Age Factors; Antifungal Agents; Child; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Immunocompromised Host; Invasive Fungal Infections; Off-Label Use; Triazoles	2018
Invasive Rhinosinusitis Caused by Lasiodiplodia theobromae in an Allogeneic Hematopoietic Cell Transplant Recipient Case Report and Review of Literature. Mycopathologia, 2018, Volume: 183, Issue:5 Topics: Antifungal Agents; Ascomycota; Debridement; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Rhinitis; Sinusitis; Transplant Recipients; Transplantation, Homologous; Treatment Outcome; Triazoles	2018
Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature. Mycopathologia, 2019, Volume: 184, Issue:1 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Cunninghamella; Debridement; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hemochromatosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Treatment Outcome; Triazoles	2019
European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. The Journal of antimicrobial chemotherapy, 2018, 12-01, Volume: 73, Issue:12 Topics: Adult; Antifungal Agents; Congresses as Topic; Europe; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Fungal Infections; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Factors; Triazoles	2018
Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019, Volume: 25, Issue:7 Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Management; Drug Resistance, Fungal; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Triazoles	2019
Broad spectrum triazoles for invasive mould infections in adults: Which drug and when? Medical mycology, 2019, Apr-01, Volume: 57, Issue:Supplement Topics: Antifungal Agents; Chemoprevention; Early Diagnosis; Humans; Immunocompromised Host; Invasive Fungal Infections; Secondary Prevention; Triazoles	2019
Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis. Expert review of clinical pharmacology, 2016, Volume: 9, Issue:7 Topics: Animals; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles	2016
Isavuconazonium sulfate: a triazole prodrug for invasive fungal infections. The International journal of pharmacy practice, 2017, Volume: 25, Issue:1 Topics: Antifungal Agents; Humans; Invasive Fungal Infections; Nitriles; Prodrugs; Pyridines; Triazoles	2017
Phellinus species: An emerging cause of refractory fungal infections in patients with X-linked chronic granulomatous disease. Mycoses, 2017, Volume: 60, Issue:3 Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Basidiomycota; Brain; DNA, Ribosomal Spacer; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lung; Male; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Young Adult	2017
New facets of antifungal therapy. Virulence, 2017, 02-17, Volume: 8, Issue:2 Topics: Antifungal Agents; Drug Discovery; Drug Synergism; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Invasive Fungal Infections; Mycoses; Polyenes; Triazoles	2017
Clinical hepatotoxicity associated with antifungal agents. Expert opinion on drug safety, 2017, Volume: 16, Issue:2 Topics: Amphotericin B; Animals; Antifungal Agents; Chemical and Drug Induced Liver Injury; Drug Interactions; Echinocandins; Humans; Invasive Fungal Infections; Liver Function Tests; Triazoles	2017
An update on the safety and interactions of antifungal drugs in stem cell transplant recipients. Expert opinion on drug safety, 2017, Volume: 16, Issue:3 Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Interactions; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Triazoles	2017

Trials

15 trial(s) available for triazoles and Disseminated Fungal Infection

Article	Year
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:2 Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole	2023
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn). The Journal of antimicrobial chemotherapy, 2019, 11-01, Volume: 74, Issue:11 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Compounding; Female; Humans; Infant; Infant, Newborn; Invasive Fungal Infections; Male; Matched-Pair Analysis; Middle Aged; Mucorales; Mucormycosis; Prospective Studies; Registries; Triazoles; Young Adult	2019
A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant. Journal of the Pediatric Infectious Diseases Society, 2021, Apr-30, Volume: 10, Issue:4 Topics: Adolescent; Adult; Antifungal Agents; Caspofungin; Child; Child, Preschool; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Mycoses; Triazoles; Young Adult	2021
Clinical experience with isavuconazole in healthy volunteers and patients with invasive aspergillosis in China, and the results from an exposure-response analysis. Mycoses, 2021, Volume: 64, Issue:4 Topics: Administration, Intravenous; Administration, Oral; Antifungal Agents; Asian People; Aspergillosis; China; Healthy Volunteers; Human Experimentation; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Treatment Outcome; Triazoles	2021
Isavuconazole Treatment of Invasive Fungal Sinusitis: A Post Hoc Analysis of the SECURE and VITAL Trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 09-15, Volume: 73, Issue:6 Topics: Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Sinusitis; Triazoles	2021
Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jun-01, Volume: 64, Issue:11 Topics: Adult; Aged; Biomarkers; Drug Monitoring; Female; Galactose; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Logistic Models; Male; Mannans; Middle Aged; Nitriles; Proportional Hazards Models; Pyridines; Survival Analysis; Treatment Outcome; Triazoles	2017
Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12 Topics: Alanine Transaminase; Antifungal Agents; Aspartate Aminotransferases; Aspergillosis; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Triazoles	2017
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease. The Journal of antimicrobial chemotherapy, 2017, Dec-01, Volume: 72, Issue:12 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Triazoles; Young Adult	2017
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species. Mycoses, 2018, Volume: 61, Issue:7 Topics: Administration, Intravenous; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Treatment Outcome; Triazoles	2018
Isavuconazole for treatment of rare invasive fungal diseases. Mycoses, 2018, Volume: 61, Issue:8 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Survival Analysis; Treatment Outcome; Triazoles; Young Adult	2018
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole. Mycoses, 2018, Volume: 61, Issue:11 Topics: Adult; Aged; Antifungal Agents; Female; Fungi; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole	2018
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole	2019
Variability and exposure-response relationships of isavuconazole plasma concentrations in the Phase 3 SECURE trial of patients with invasive mould diseases. The Journal of antimicrobial chemotherapy, 2019, 03-01, Volume: 74, Issue:3 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Male; Nitriles; Pyridines; Treatment Outcome; Triazoles	2019
A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia. PloS one, 2019, Volume: 14, Issue:3 Topics: Administration, Oral; Adolescent; Age Factors; Antifungal Agents; Antineoplastic Agents; Area Under Curve; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunocompromised Host; Infant; Invasive Fungal Infections; Male; Neoplasms; Neutropenia; Prospective Studies; Triazoles	2019
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:6 Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Biological Availability; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucormycosis; Mucositis; Nitriles; Pyridines; Treatment Outcome; Triazoles; Young Adult	2017

Other Studies

101 other study(ies) available for triazoles and Disseminated Fungal Infection

Article	Year
Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance. Medical mycology, 2021, Dec-08, Volume: 60, Issue:1 Topics: Animals; Antifungal Agents; Aspergillosis; Clinical Decision Rules; Invasive Fungal Infections; Triazoles; Voriconazole	2021
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study. Mycoses, 2022, Volume: 65, Issue:2 Topics: Adult; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Registries; Triazoles	2022
Hepatic safety of the antifungal triazole agent posaconazole: characterization of adverse event reports in a manufacturer's safety database. Expert opinion on drug safety, 2022, Volume: 21, Issue:8 Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Humans; Invasive Fungal Infections; Triazoles	2022
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-29, Volume: 75, Issue:9 Topics: Adult; Antifungal Agents; Azoles; Chemical and Drug Induced Liver Injury; Echinocandins; Fungi; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Retrospective Studies; Triazoles; Voriconazole	2022
Real-World Comparison of Isavuconazole and Voriconazole in Terms of the Need for Dosage Adjustments Guided by Clinical Pharmacological Advice During Primary Prophylaxis of Invasive Fungal Infections in Pediatric Patients with Hemato-Oncological Malignanci Therapeutic drug monitoring, 2022, 10-01, Volume: 44, Issue:5 Topics: Antifungal Agents; Azoles; Child; Humans; Invasive Fungal Infections; Neoplasms; Nitriles; Pyridines; Retrospective Studies; Triazoles; Voriconazole	2022
Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2022, 07-22, Volume: 79, Issue:15 Topics: Adult; Aspergillosis; Extracorporeal Membrane Oxygenation; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Respiratory Insufficiency; Triazoles	2022
Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study. BMC infectious diseases, 2022, May-15, Volume: 22, Issue:1 Topics: Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Retrospective Studies; Triazoles	2022
Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China. Frontiers in public health, 2022, Volume: 10 Topics: Antifungal Agents; Cost-Benefit Analysis; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Mycoses; Tablets; Triazoles	2022
Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients. Medical mycology, 2022, Sep-02, Volume: 60, Issue:9 Topics: Animals; Antifungal Agents; Humans; Invasive Fungal Infections; Lung; Retrospective Studies; Transplant Recipients; Triazoles; Voriconazole	2022
Design, synthesis and antifungal activities of novel triazole derivatives with selenium-containing hydrophobic side chains. Bioorganic & medicinal chemistry letters, 2022, 12-15, Volume: 78 Topics: Animals; Antifungal Agents; Fluconazole; Humans; Invasive Fungal Infections; Mammals; Selenium; Triazoles	2022
Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice. Transplantation, 2023, 03-01, Volume: 107, Issue:3 Topics: Adult; Antifungal Agents; Aspergillosis; Fungi; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Organ Transplantation; Retrospective Studies; Tacrolimus; Transplant Recipients; Triazoles	2023
Health economic analysis of patients treated with isavuconazole in a German comprehensive cancer centre. Mycoses, 2023, Volume: 66, Issue:5 Topics: Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Neoplasms; Nitriles; Triazoles	2023
Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 07-05, Volume: 77, Issue:1 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Prospective Studies; Real-Time Polymerase Chain Reaction; Triazoles	2023
Context of instauration and evolution under isavuconazole, a 2-year prospective real-life study. Medical mycology, 2023, Apr-03, Volume: 61, Issue:4 Topics: Animals; Antifungal Agents; Aspergillosis; Invasive Fungal Infections; Mucormycosis; Prospective Studies; Triazoles	2023
Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal Disease. Clinical pharmacokinetics, 2023, Volume: 62, Issue:7 Topics: Administration, Oral; Adult; Antifungal Agents; Child; Humans; Invasive Fungal Infections; Retrospective Studies; Suspensions; Tablets; Triazoles	2023
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies. Scientific reports, 2023, 04-25, Volume: 13, Issue:1 Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Nitriles; Prospective Studies; Triazoles; Voriconazole	2023
In vitro antifungal susceptibility profile and genotypic characterization of clinical Aspergillus isolates in Eastern China on behalf of Eastern China Invasive Fungi Infection Group. Medical mycology, 2023, Sep-04, Volume: 61, Issue:9 Topics: Animals; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Azoles; Drug Resistance, Fungal; Fungal Proteins; Genotype; Invasive Fungal Infections; Microbial Sensitivity Tests; Phylogeny; Triazoles	2023
Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia. Scientific reports, 2023, 11-01, Volume: 13, Issue:1 Topics: Antifungal Agents; Child; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles; Voriconazole	2023
Posaconazole Serum Drug Levels Associated With Pseudohyperaldosteronism. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 06-10, Volume: 70, Issue:12 Topics: Aged; Antifungal Agents; Humans; Invasive Fungal Infections; Retrospective Studies; Triazoles	2020
Invasive mucormycosis during treatment for acute lymphoblastic leukaemia-successful management of two life-threatening diseases. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020, Volume: 28, Issue:5 Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Invasive Fungal Infections; Lung Diseases, Fungal; Male; Mercaptopurine; Methotrexate; Mucorales; Mucormycosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Triazoles; Vincristine	2020
Treatment Failure of Isavuconazole in a Patient with Cryptococcosis. Mycopathologia, 2019, Volume: 184, Issue:5 Topics: Antifungal Agents; Cryptococcosis; Humans; Invasive Fungal Infections; Lung Diseases, Fungal; Male; Middle Aged; Nitriles; Pyridines; Treatment Failure; Triazoles	2019
Real-life use of isavuconazole outside the hematological wards. European journal of internal medicine, 2019, Volume: 70 Topics: Adult; Aged; Antifungal Agents; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Italy; Male; Middle Aged; Nitriles; Pyridines; Triazoles	2019
Use of triazoles for the treatment of invasive aspergillosis: A three-year cohort analysis. Mycoses, 2020, Volume: 63, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Cohort Studies; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole	2020
Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level. Mycoses, 2020, Volume: 63, Issue:1 Topics: Administration, Oral; Adult; Antifungal Agents; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Hypoalbuminemia; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Risk Factors; Suspensions; Tablets; Treatment Outcome; Triazoles	2020
Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system. Medical mycology, 2020, Jun-01, Volume: 58, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Central Nervous System Fungal Infections; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Drug Resistance, Fungal; Female; Fungi; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Survival Analysis; Triazoles; Young Adult	2020
Evaluation of posaconazole antifungal prophylaxis in reducing the incidence of invasive aspergillosis in patients with acute myeloid leukemia. Current research in translational medicine, 2020, Volume: 68, Issue:1 Topics: Adult; Aerosols; Air Filters; Air Microbiology; Air Pollution, Indoor; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus; Combined Modality Therapy; Environmental Exposure; Febrile Neutropenia; Female; Filtration; France; Hematopoietic Stem Cell Transplantation; Hospital Design and Construction; Hospitals, Teaching; Humans; Incidence; Invasive Fungal Infections; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Prospective Studies; Retrospective Studies; Spores, Fungal; Triazoles	2020
Evaluation of target attainment of oral posaconazole suspension in immunocompromised children. The Journal of antimicrobial chemotherapy, 2020, 03-01, Volume: 75, Issue:3 Topics: Antifungal Agents; Child; Humans; Infant; Invasive Fungal Infections; Retrospective Studies; Triazoles	2020
Successful Treatment of Invasive Fungal Infection Due to Highly Resistant Aspergillus calidoustus in an Allogeneic Hematopoietic Cell Transplant Recipient. Mycopathologia, 2020, Volume: 185, Issue:2 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Azoles; Drug Resistance, Fungal; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Middle Aged; Nitriles; Primary Myelofibrosis; Pyridines; Triazoles	2020
Itraconazole vs. posaconazole for antifungal prophylaxis in patients with acute myeloid leukemia undergoing intensive chemotherapy: A retrospective study. International journal of antimicrobial agents, 2020, Volume: 55, Issue:3 Topics: Adult; Antifungal Agents; Antineoplastic Agents; Humans; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles	2020
Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection. Journal of infection in developing countries, 2018, 09-30, Volume: 12, Issue:9 Topics: Adolescent; Adult; Allografts; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2018
Prolonged survival after disseminated Rhinocladiella infection treated with surgical excision and posaconazole. Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:2 Topics: Aged; Amphotericin B; Antifungal Agents; Arthritis, Infectious; Ascomycota; Brain Abscess; Central Nervous System Fungal Infections; Humans; Immunocompromised Host; Invasive Fungal Infections; Kidney Transplantation; Male; Treatment Outcome; Triazoles	2020
A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2020, Volume: 26, Issue:6 Topics: Adult; Aged; Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Triazoles	2020
Safety of Isavuconazonium Sulfate in Pediatrics Patients With Hematologic Malignancies and Hematopoietic Cell Transplantation With Invasive Fungal Infections: A Real World Experience. Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:4 Topics: Adolescent; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Nitriles; Pyridines; Retrospective Studies; Triazoles	2020
18F-FDG Positron Emission Tomography (PET) Scan as a Useful Tool to Assess Response to Antimycotic Therapy in Disseminated Invasive Mycosis in Acute Myeloid Leukemia. Mycopathologia, 2020, Volume: 185, Issue:3 Topics: Aged; Anidulafungin; Antifungal Agents; Drug Combinations; Humans; Immunocompromised Host; Invasive Fungal Infections; Kidney; Leukemia, Myeloid, Acute; Liver; Male; Mycoses; Nitriles; Positron-Emission Tomography; Pyridines; Spleen; Treatment Outcome; Triazoles	2020
Disseminated Lomentospora prolificans infection in a patient on idelalisib-rituximab therapy for relapsed chronic lymphocytic leukaemia. Annals of hematology, 2020, Volume: 99, Issue:10 Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance, Multiple, Fungal; Drug Substitution; Fatal Outcome; Febrile Neutropenia; Female; Filgrastim; Fluconazole; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Piperacillin, Tazobactam Drug Combination; Purines; Quinazolinones; Recurrence; Rituximab; Scedosporium; Triazoles; Valacyclovir; Vidarabine	2020
Initial posaconazole dosing to achieve therapeutic serum posaconazole concentrations among children, adolescents, and young adults receiving delayed-release tablet and intravenous posaconazole. Pediatric transplantation, 2020, Volume: 24, Issue:6 Topics: Administration, Oral; Adolescent; Antifungal Agents; Body Weight; Child; Child, Preschool; Delayed-Action Preparations; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Invasive Fungal Infections; Male; Neoplasms; Retrospective Studies; Tablets; Treatment Outcome; Triazoles; Young Adult	2020
Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report. Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:6 Topics: Adult; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Triazoles; Voriconazole	2020
Evaluating posaconazole dosing regimens of the different formulations against Aspergillus spp. in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation. International journal of antimicrobial agents, 2020, Volume: 56, Issue:4 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Delayed-Action Preparations; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Triazoles	2020
Posaconazole and fluconazole prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Volume: 54, Issue:6 Topics: Antibiotic Prophylaxis; Antifungal Agents; Child; Child, Preschool; Female; Fluconazole; Humans; Induction Chemotherapy; Invasive Fungal Infections; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Treatment Outcome; Triazoles	2021
Isavuconazole for the prophylaxis and treatment of invasive fungal disease: A single-center experience. Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:2 Topics: Antifungal Agents; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Retrospective Studies; Triazoles	2021
Latest Thoughts on Treating Pediatric Mucormycosis. Journal of the Pediatric Infectious Diseases Society, 2020, Nov-10, Volume: 9, Issue:5 Topics: Amphotericin B; Antifungal Agents; Biopsy; Child; Debridement; Humans; Immunocompromised Host; Invasive Fungal Infections; Mucorales; Mucormycosis; Salvage Therapy; Tomography, X-Ray Computed; Triazoles	2020
Characterization of Isavuconazole serum concentrations after enteral feeding tube administration in a hospitalized cohort: A case series. Journal of clinical pharmacy and therapeutics, 2021, Volume: 46, Issue:2 Topics: Adult; Antifungal Agents; Drug Administration Routes; Enteral Nutrition; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Triazoles	2021
A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication. Therapeutic drug monitoring, 2021, 08-01, Volume: 43, Issue:4 Topics: Administration, Oral; Antifungal Agents; Child; Humans; Immunocompromised Host; Invasive Fungal Infections; Prospective Studies; Triazoles	2021
Investigating the impact of posaconazole prophylaxis on systematic fungal screening using galactomannan antigen, Aspergillus fumigatus qPCR, and Mucorales qPCR. Journal de mycologie medicale, 2021, Volume: 31, Issue:2 Topics: Aspergillus fumigatus; Galactose; Humans; Invasive Fungal Infections; Mannans; Mass Screening; Mucorales; Real-Time Polymerase Chain Reaction; Retrospective Studies; Triazoles	2021
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response. BMC infectious diseases, 2021, Mar-24, Volume: 21, Issue:1 Topics: Aspergillosis; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Invasive Fungal Infections; Organ Transplantation; Patient Outcome Assessment; Practice Guidelines as Topic; Transplant Recipients; Triazoles	2021
Comparison of invasive fungal diseases between patients with acute myeloid leukemia receiving posaconazole prophylaxis and those not receiving prophylaxis: A single-center, observational, case-control study in South Korea. Medicine, 2021, May-21, Volume: 100, Issue:20 Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Case-Control Studies; Female; Humans; Incidence; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Seoul; Treatment Outcome; Triazoles	2021
Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients. Antimicrobial agents and chemotherapy, 2021, 07-16, Volume: 65, Issue:8 Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Humans; Infant; Invasive Fungal Infections; Nitriles; Pyridines; Triazoles	2021
Real-world assessment of the effectiveness of posaconazole for the prophylaxis and treatment of invasive fungal infections in hematological patients: A retrospective observational study. Medicine, 2021, Jul-30, Volume: 100, Issue:30 Topics: Adult; Antifungal Agents; Female; Hematologic Diseases; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Triazoles; Young Adult	2021
New pharmacological opportunities for the treatment of invasive mould diseases. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1 Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole	2017
Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Administration, Intravenous; Administration, Oral; Algorithms; Antifungal Agents; Cohort Studies; Drug Compounding; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Pre-Exposure Prophylaxis; Retrospective Studies; Tablets; Tertiary Care Centers; Treatment Outcome; Triazoles	2017
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. International journal of antimicrobial agents, 2017, Volume: 50, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hospitals, University; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Survival Analysis; Texas; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2017
Invasive fungal infection following chemotherapy for acute myeloid leukaemia-Experience from a developing country. Mycoses, 2017, Volume: 60, Issue:10 Topics: Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Developing Countries; Female; Humans; India; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Triazoles; Young Adult	2017
Evaluation of Posaconazole Serum Concentrations from Delayed-Release Tablets in Patients at High Risk for Fungal Infections. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:10 Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Female; Fusarium; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucorales; Mucositis; Retrospective Studies; Triazoles	2017
Retrospective analysis of goal drug level attainment of posaconazole for invasive fungal infection prophylaxis in patients with acute myeloid leukemia pre- and post-switch to tablet formulation. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2018, Volume: 24, Issue:8 Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Case-Control Studies; Drug Administration Schedule; Drug Compounding; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Patient Care Planning; Post-Exposure Prophylaxis; Retrospective Studies; Tablets; Triazoles; Young Adult	2018
Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain. Advances in therapy, 2017, Volume: 34, Issue:9 Topics: Adult; Aged; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Humans; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Myelodysplastic Syndromes; Solutions; Spain; Tablets; Triazoles	2017
Efficacy and safety of posaconazole in hematopoietic stem cell transplantation patients with invasive fungal disease. Future microbiology, 2017, Volume: 12 Topics: Adult; Antifungal Agents; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Multivariate Analysis; Neutropenia; Primary Prevention; Regression Analysis; Retrospective Studies; Steroids; Time Factors; Transplantation Conditioning; Treatment Outcome; Triazoles	2017
Risk factors for subtherapeutic levels of posaconazole tablet. The Journal of antimicrobial chemotherapy, 2017, 10-01, Volume: 72, Issue:10 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Middle Aged; Multivariate Analysis; Pre-Exposure Prophylaxis; Retrospective Studies; Risk Factors; Tablets; Triazoles; Young Adult	2017
Posaconazole liquid vs tablet formulation in lung transplant recipients. Mycoses, 2018, Volume: 61, Issue:3 Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Aspergillosis; Delayed-Action Preparations; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Longitudinal Studies; Lung Transplantation; Male; Middle Aged; Retrospective Studies; Suspensions; Tablets; Transplant Recipients; Triazoles; Young Adult	2018
Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison. Mycoses, 2018, Volume: 61, Issue:3 Topics: Adult; Aged; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Pre-Exposure Prophylaxis; Retrospective Studies; Treatment Failure; Triazoles	2018
Fungal Prophylaxis with a Gastro-Resistant Posaconazole Tablet for Patients with Hematological Malignancies in the POSANANTES Study. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2 Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Female; Fungi; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Stomach; Tablets; Triazoles; Young Adult	2018
Isavuconazole shortens the QTc interval. Mycoses, 2018, Volume: 61, Issue:4 Topics: Adult; Antifungal Agents; Electrocardiography; Female; Heart Conduction System; Humans; Invasive Fungal Infections; Male; Nitriles; Pyridines; Triazoles	2018
Hepatic veno-occlusive disease during isavuconazole administration. Journal of chemotherapy (Florence, Italy), 2018, Volume: 30, Issue:1 Topics: Antifungal Agents; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Nitriles; Pyridines; Triazoles; Young Adult	2018
Alternate-day dosing of posaconazole tablets in children leads to efficient plasma levels. European journal of haematology, 2018, Volume: 101, Issue:1 Topics: Age Factors; Antifungal Agents; Child; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Male; Treatment Outcome; Triazoles	2018
Breakthrough Invasive Fungal Infections on Isavuconazole Prophylaxis and Treatment: What Is Happening in the Real-World Setting? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 09-14, Volume: 67, Issue:7 Topics: Adult; Aged; Antifungal Agents; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Triazoles	2018
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study. Journal de mycologie medicale, 2018, Volume: 28, Issue:2 Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult	2018
[Use of posaconazole in children: Experience in a tertiary pediatric hospital]. Archivos argentinos de pediatria, 2018, 06-01, Volume: 116, Issue:3 Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Hospitals, Pediatric; Humans; Invasive Fungal Infections; Retrospective Studies; Tertiary Care Centers; Time Factors; Triazoles	2018
Breakthrough Fungal Infections in Patients With Leukemia Receiving Isavuconazole. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 10-30, Volume: 67, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidemia; Electronic Health Records; Female; Humans; Invasive Fungal Infections; Leukemia; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Triazoles; Young Adult	2018
Low dose posaconazole delayed release tablets for fungal prophylaxis in lung transplant recipients. Clinical transplantation, 2018, Volume: 32, Issue:8 Topics: Antibiotic Prophylaxis; Antifungal Agents; Delayed-Action Preparations; Drug Monitoring; Female; Follow-Up Studies; Humans; Invasive Fungal Infections; Lung Transplantation; Male; Middle Aged; Prognosis; Retrospective Studies; Tablets; Tissue Distribution; Transplant Recipients; Triazoles	2018
Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 10-30, Volume: 67, Issue:10 Topics: Adult; Antifungal Agents; Chemoprevention; Disease Management; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Prospective Studies; Risk Factors; Transplantation, Homologous; Triazoles	2018
Impact of patient education on plasma concentrations and effectiveness of posaconazole oral suspension under clinical conditions. Basic & clinical pharmacology & toxicology, 2019, Volume: 124, Issue:1 Topics: Administration, Oral; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Female; Humans; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Patient Education as Topic; Program Evaluation; Prospective Studies; Retrospective Studies; Suspensions; Treatment Outcome; Triazoles; Young Adult	2019
Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:10 Topics: Administration, Oral; Aged; Antifungal Agents; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Suspensions; Triazoles	2018
Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib. Leukemia & lymphoma, 2019, Volume: 60, Issue:2 Topics: Adenine; Antifungal Agents; Humans; Invasive Fungal Infections; Nitriles; Piperidines; Pyrazoles; Pyridines; Pyrimidines; Treatment Outcome; Triazoles	2019
Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:2 Topics: Adult; Aged; Antifungal Agents; Female; Humans; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Triazoles; Voriconazole	2019
Cutaneous mucormycosis. Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:2 Topics: Aged; Amphotericin B; Antifungal Agents; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Fungal Infections; Male; Mucormycosis; Multiple Organ Failure; Rhizopus; Shock, Septic; Skin; Triazoles	2019
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation. Critical care (London, England), 2018, 12-22, Volume: 22, Issue:1 Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchopulmonary Sequestration; Extracorporeal Membrane Oxygenation; Humans; Influenza, Human; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Triazoles; Voriconazole	2018
Therapeutic drug concentrations of isavuconazole following the administration of isavuconazonium sulfate capsules via gastro-jejunum tube: A case report. Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:2 Topics: Aged; Antifungal Agents; Aspergillosis; Capsules; Drug Monitoring; Enteral Nutrition; Humans; Immunocompromised Host; Invasive Fungal Infections; Jejunum; Lung Transplantation; Male; Nitriles; Pyridines; Triazoles	2019
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden. BMC infectious diseases, 2019, Feb-11, Volume: 19, Issue:1 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Case-Control Studies; Cost-Benefit Analysis; Decision Trees; Female; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Quality-Adjusted Life Years; Sweden; Triazoles; Voriconazole	2019
Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017). Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019, Volume: 25, Issue:5 Topics: Antifungal Agents; Fluconazole; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Yeasts	2019
Breakthrough invasive fungal diseases in acute myeloid leukemia patients receiving mould active triazole primary prophylaxis after intensive chemotherapy: An Italian consensus agreement on definitions and management. Medical mycology, 2019, Apr-01, Volume: 57, Issue:Supplement Topics: Antifungal Agents; Chemoprevention; Disease Management; Humans; Invasive Fungal Infections; Italy; Leukemia, Myeloid, Acute; Triazoles	2019
Why do lung transplant patients discontinue triazole prophylaxis? Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3 Topics: Adult; Aged; Antifungal Agents; Drug Interactions; Female; Humans; Invasive Fungal Infections; Itraconazole; Lung Transplantation; Male; Medication Adherence; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Voriconazole	2019
Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center. Annals of clinical microbiology and antimicrobials, 2019, Mar-20, Volume: 18, Issue:1 Topics: Academic Medical Centers; Adult; Aged; Antifungal Agents; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Triazoles; Voriconazole; Young Adult	2019
Intravenous and tablet formulation of posaconazole in antifungal therapy and prophylaxis: A retrospective, non-interventional, multicenter analysis of hematological patients treated in tertiary-care hospitals. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2019, Volume: 83 Topics: Administration, Intravenous; Adult; Aged; Antifungal Agents; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Tablets; Tertiary Care Centers; Treatment Outcome; Triazoles; Young Adult	2019
Tissue Distribution and Penetration of Isavuconazole at the Site of Infection in Experimental Invasive Aspergillosis in Mice with Underlying Chronic Granulomatous Disease. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:6 Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Chromatography, Liquid; Disease Models, Animal; Granulomatous Disease, Chronic; Invasive Fungal Infections; Male; Mice; Nitriles; Prodrugs; Pyridines; Tandem Mass Spectrometry; Tissue Distribution; Triazoles	2019
Isavuconazole to prevent invasive fungal infection in immunocompromised adults: Initial experience at an academic medical centre. Mycoses, 2019, Volume: 62, Issue:8 Topics: Academic Medical Centers; Adult; Antifungal Agents; Chemoprevention; Cost-Benefit Analysis; Female; Humans; Immunocompromised Host; Inpatients; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Oregon; Pyridines; Retrospective Studies; Risk Factors; Triazoles	2019
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy. The Journal of antimicrobial chemotherapy, 2019, 08-01, Volume: 74, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; ROC Curve; Serum; Triazoles	2019
Posaconazole therapeutic drug monitoring in clinical practice and longitudinal analysis of the effect of routine laboratory measurements on posaconazole concentrations. Mycoses, 2019, Volume: 62, Issue:8 Topics: Administration, Oral; Aged; Antifungal Agents; Antimicrobial Stewardship; Clinical Laboratory Techniques; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Tablets; Triazoles	2019
The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United Kingdom. Journal of medical economics, 2020, Volume: 23, Issue:1 Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Trees; Diagnosis, Differential; Health Expenditures; Health Resources; Health Services; Hospitalization; Humans; Invasive Fungal Infections; Models, Economic; Nitriles; Prescription Fees; Pyridines; Quality-Adjusted Life Years; State Medicine; Survival Analysis; Triazoles; Uncertainty; United Kingdom; Voriconazole	2020
Impact of Triazole Therapeutic Drug Monitoring Availability and Timing. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult	2019
Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway Aspergillosis. Transplantation, 2019, Volume: 103, Issue:12 Topics: Administration, Inhalation; Adult; Aerosols; Antifungal Agents; Aspergillosis; Bronchoscopy; Feasibility Studies; Female; Humans; Invasive Fungal Infections; Lung Transplantation; Respiratory Tract Infections; Triazoles; Voriconazole	2019
Breakthrough invasive fungal infection under the use of posaconazole and voriconazole. Journal of the Formosan Medical Association = Taiwan yi zhi, 2016, Volume: 115, Issue:5 Topics: Antifungal Agents; Colletotrichum; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Opportunistic Infections; Triazoles; Voriconazole	2016
Comparison of posaconazole serum concentrations from haematological cancer patients on posaconazole tablet and oral suspension for treatment and prevention of invasive fungal infections. Mycoses, 2016, Volume: 59, Issue:4 Topics: Adult; Aged; Antifungal Agents; Chemoprevention; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Neoplasms; Retrospective Studies; Serum; Suspensions; Tablets; Triazoles; Young Adult	2016
Pharmacokinetics of Posaconazole Suspension in Lung Transplant Patients with and without Cystic Fibrosis. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Adult; Aged; Antifungal Agents; Cystic Fibrosis; Female; Humans; Invasive Fungal Infections; Lung Transplantation; Male; Middle Aged; Triazoles	2016
Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis? Mycoses, 2016, Volume: 59, Issue:8 Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic-Myeloproliferative Diseases; Neutropenia; Numbers Needed To Treat; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Triazoles	2016
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9 Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Cohort Studies; Echinocandins; Female; Hematologic Diseases; Humans; Incidence; Invasive Fungal Infections; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Triazoles; Young Adult	2016
Utilization of posaconazole oral suspension or delayed-released tablet salvage treatment for invasive fungal infection. Mycoses, 2016, Volume: 59, Issue:11 Topics: Administration, Oral; Adult; Aged; Alternaria; Antifungal Agents; Aspergillus; Delayed-Action Preparations; Fatal Outcome; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucormycosis; Retrospective Studies; Salvage Therapy; Suspensions; Tablets; Treatment Outcome; Triazoles	2016
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant. Mycoses, 2017, Volume: 60, Issue:2 Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Itraconazole; Spain; Triazoles; Voriconazole	2017
Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:12 Topics: Adolescent; Adult; Aged; Allografts; Antifungal Agents; Blood Donors; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Premedication; Salvage Therapy; Survival Analysis; Triazoles; Young Adult	2016
Skin lesion in a patient with acute myeloid leukemia. Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:1 Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Biopsy; Debridement; Dermatomycoses; Febrile Neutropenia; Forearm; Humans; Immunocompromised Host; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Mucormycosis; Polymerase Chain Reaction; Rhizopus; RNA, Fungal; Triazoles	2017
Comparison of serum concentrations between different dosing strategies of posaconazole delayed-release tablet at a large academic medical centre. Mycoses, 2017, Volume: 60, Issue:4 Topics: Academic Medical Centers; Administration, Oral; Adult; Antifungal Agents; Delayed-Action Preparations; Drug Dosage Calculations; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Tablets; Triazoles	2017
Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2017, Jan-01, Volume: 74, Issue:1 Topics: Antifungal Agents; Chemistry, Pharmaceutical; Drug Incompatibility; Drug Stability; Emulsions; Glucose; Humans; Infusions, Intravenous; Injections, Intravenous; Invasive Fungal Infections; Nephelometry and Turbidimetry; Nitriles; Pyridines; Sodium Chloride; Solubility; Time Factors; Triazoles	2017
The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK. Future microbiology, 2017, Volume: 12 Topics: Amphotericin B; Antifungal Agents; Case-Control Studies; Drug Costs; Hospitalization; Humans; Invasive Fungal Infections; Models, Economic; Mucormycosis; Nitriles; Pyridines; Triazoles; United Kingdom	2017